Daxor Corp
NASDAQ:DXR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.19
10.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Daxor Corp
Gross Margin
Daxor Corp
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 46.2m USD |
| Gross Margin |
-383%
|
| Country | US |
| Market Cap | 204.2B USD |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 193.1B USD |
| Gross Margin |
67%
|
| Country | US |
| Market Cap | 148.4B USD |
| Gross Margin |
64%
|
| Country | US |
| Market Cap | 132.7B USD |
| Gross Margin |
69%
|
| Country | IE |
| Market Cap | 109.9B USD |
| Gross Margin |
65%
|
| Country | US |
| Market Cap | 64.8B USD |
| Gross Margin |
45%
|
| Country | DE |
| Market Cap | 56.9B EUR |
| Gross Margin |
38%
|
| Country | CN |
| Market Cap | 323.2B CNY |
| Gross Margin |
64%
|
| Country | US |
| Market Cap | 42.2B USD |
| Gross Margin |
79%
|
| Country | US |
| Market Cap | 37.9B USD |
| Gross Margin |
41%
|
Daxor Corp
Glance View
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Daxor Corp's most recent financial statements, the company has Gross Margin of -383.2%.
You don't have any saved screeners yet
